NCT06697821View on ClinicalTrials.gov

The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis

CompletedOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2024

Conditions
Gastric Cancer
Interventions
PROCEDURE

D2＋CME

Whether to perform the whole mesogastric excision

Trial Locations (1)

430000

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Jichao Qin

OTHER

NCT06697821 - The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis | Biotech Hunter | Biotech Hunter